Chronic Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-11-15Clinical Trial Update: Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 clinical trial evaluating Anti-Tac(Fv)-PE38 (LMB-2) for chronic lymphocytic leukemia completed with results posted.
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
This clinical trial evaluated non-myeloablative allogeneic stem cell transplantation with matched unrelated donors across several hematologi…
-
CLINICAL_TRIALS trial_result · 2012-10-12Clinical Trial Update: Dasatinib in Relapsed Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 clinical trial evaluating dasatinib in relapsed chronic lymphocytic leukemia has been completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-01Clinical Trial Update: Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy [Phase 1]
Phase 1 dose-finding study of HCD122 in Chronic Lymphocytic Leukemia patients who relapsed or failed prior fludarabine therapy has been term…
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies [Phase 1]
Phase 1 dose-escalation study of CAL-101 in relapsed or refractory hematologic malignancies has completed, evaluating safety and preliminary…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation [NA]
This clinical trial evaluated CD8 donor lymphocyte infusion for relapse or residual disease after allogeneic stem cell transplantation. The …
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
A Phase 2 study of EL625 in patients with persistent chronic lymphocytic leukemia or small lymphocytic lymphoma was terminated, with results…
-
CLINICAL_TRIALS trial_result · 2012-08-10Clinical Trial Update: Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial update reporting results for subcutaneous alemtuzumab (CAMPATH, MabCampath) in relapsed/refractory B-cell chronic lymphocytic …
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia [Phase 3]
Clinical trial update for bendamustine hydrochloride injection in previously untreated chronic lymphocytic leukemia (Phase 3).
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS [Phase 1, Phase 2]
An allogeneic transplant regimen using Mylotarg with fludarabine and melphalan was studied for acute myeloid leukemia, chronic myeloid leuke…
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia [Phase 1]
A Phase 1 study evaluating weekly clofarabine for relapsed/refractory chronic lymphocytic leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Oral Valganciclovir Versus Valacyclovir [Phase 2]
A Phase 2 clinical trial comparing oral valganciclovir versus valacyclovir in patients with chronic lymphocytic leukemia and leukemia, which…
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Continuous Infusion of Campath-1H Followed by Subcutaneous Injections in Previously Treated Patients With Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 clinical trial update of continuous infusion Campath-1H (alemtuzumab) followed by subcutaneous injections in previously treated chro…
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia [Phase 1, Phase 2]
This clinical trial investigates a combination of chemotherapy with peripheral stem cell transplantation to treat refractory chronic lymphoc…
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL) [Phase 4]
A Phase 4 clinical trial evaluated retreatment and maintenance therapy with ofatumumab in patients with chronic lymphocytic leukemia, with r…
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Phase 2 trial evaluating SDX-101 (R-Etodolac) with chlorambucil and chlorambucil alone in chronic lymphocytic leukemia. The study status is …
-
CLINICAL_TRIALS trial_result · 2012-05-23Clinical Trial Update: Treatment of Chronic Lymphocytic B-Leukemia With IL-2 and CD-40 Autologous Tumor Cells [Phase 1]
A Phase 1 clinical trial evaluating interleukin-2 in combination with CD-40–activated autologous tumor cells for chronic lymphocytic leukemi…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas [Phase 1]
A Phase 1 safety study of SNX-5422 for solid tumor malignancies and lymphoid cancers has been completed.
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL [Phase 2]
A Phase 2 study assessing cladribine and rituximab as induction therapy, followed by rituximab and stem cell mobilization in patients with c…
-
CLINICAL_TRIALS trial_result · 2012-05-08Clinical Trial Update: Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial evaluating Rituximab, Alemtuzumab, and GM-CSF as first-line therapy in early-stage chronic lymphocytic leukemia has completed …
-
CLINICAL_TRIALS trial_result · 2012-05-02Clinical Trial Update: Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients [Phase 2]
Phase 2 clinical trial evaluating GM-CSF immuno-augmentation of pneumococcal vaccination in patients with chronic lymphocytic leukemia; the …
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: LFB-R603 Dose Finding in Patients With Advanced Stage B-Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 dose-finding clinical trial update for LFB-R603 in patients with advanced stage Chronic Lymphocytic Leukemia (Phase 1; completed).
-
CLINICAL_TRIALS trial_result · 2012-04-11Clinical Trial Update: Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 clinical trial investigating rituximab, pentostatin, cyclophosphamide, and lenalidomide in previously untreated B-cell chronic lymph…
-
CLINICAL_TRIALS trial_result · 2012-03-28Clinical Trial Update: Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) [Phase 2]
A Phase 2 study of oral panobinostat (LBH589) in relapsed or refractory chronic lymphocytic leukemia and mantle cell lymphoma has been termi…
-
CLINICAL_TRIALS trial_result · 2012-03-13Clinical Trial Update: Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated the safety and potential efficacy of oral green tea extract in patients with stage 0 to II chronic lymp…